Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Feb 24, 2017, 08:45 ET Developments in the Legal Cannabis Industry

A report published by The Hemp Business Journal estimates that the Cannabidiol (CBD) market will grow to a $2.1 billion market in consumer sales...


Feb 24, 2017, 08:45 ET Cannabis Market Benefits from Legalization and Job Creation

The cannabis industry is expanding rapidly as support for cannabis legalization continues to rise in the United States. According to Arcview...


Feb 24, 2017, 08:33 ET Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology...


Feb 24, 2017, 08:30 ET ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired Inderal® XL from Cranford Pharmaceuticals, LLC and InnoPran...


Feb 24, 2017, 08:00 ET Targeting Chemokine Signaling to Overcome Radiation Resistance in Colorectal Cancer

An article published in Experimental Biology and Medicine (Volume 242, Issue 4, February, 2017) identifies a new pathway that renders colon cancers...


Feb 24, 2017, 08:00 ET Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin

Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a real-world analysis showing that Pradaxa® (dabigatran etexilate mesylate)...


Feb 24, 2017, 07:56 ET "Sound Bites" Event to Raise Funds for Tuberous Sclerosis Alliance

On Wednesday, March 1, the Tuberous Sclerosis Alliance (TS Alliance) will present Sound Bites, An Evening of Food, Wine and Music at the National...


Feb 24, 2017, 07:20 ET Healthcare Stocks on Investors' Radar -- Alkermes, Teleflex, Cascadian Therapeutics, and InspireMD

This morning, Stock-Callers.com tracks the current performances of Alkermes PLC (NASDAQ: ALKS), Teleflex Inc. (NYSE: TFX), Cascadian Therapeutics...


Feb 24, 2017, 07:20 ET Journal of Emergency Medical Services (JEMS) Partners with Asian Association for Emergency Medical Services (AAEMS)

PennWell Corporation, a diversified global media and conferences and exhibitions company, announced today a collaborative partnership between the...


Feb 24, 2017, 07:17 ET CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism

This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the...


Feb 24, 2017, 07:15 ET Research Reports Coverage on Biotech Stocks -- Puma Biotechnology, Dipexium Pharma, BioCryst Pharma, and CTI BioPharma

In today's pre-market research, Stock-Callers.com explores the Biotech arena with the following companies in focus: Puma Biotechnology Inc....


Feb 24, 2017, 07:15 ET Thrombosis Drugs Price Analysis and Strategies 2016-2021: Market Sizing, Drug Sales Forecast, Budgeting, Competitive Intelligence, HEOR, and Reimbursement - Research and Markets

Research and Markets has announced the addition of the "Thrombosis Drugs Price Analysis and Strategies - 2016" report to their offering. The...


Feb 24, 2017, 07:00 ET CytoSorbents to Report Fiscal 2016 Operating and Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


Feb 24, 2017, 06:19 ET ITL double ses profits dans ses résultats semestriels 2016/2017

ITL Limited, (ASX : ITD), une société de soins de santé diversifiée innovante, est ravie d'annoncer les excellents résultats semestriels...


Feb 24, 2017, 06:17 ET Gewinn von ITL verdoppelt sich im Halbjahresergebnis 2016/2017

ITL Limited, (ASX: ITD), ein innovatives, diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum 31. Dezember 2016 endende...


Feb 24, 2017, 06:01 ET OncoSec to Host KOL Event Focused on New ASCO-SITC Melanoma Data and Clinical Strategy on Tuesday, February 28 in New York City

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will host a Key...


Feb 24, 2017, 06:00 ET VWR Corporation Reports Fourth Quarter 2016 Financial Results

VWR Corporation (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers,...


Feb 24, 2017, 06:00 ET Urinary Incontinence Drugs Price Analysis and Strategies 2016-2021 - Research and Markets

Research and Markets has announced the addition of the "Urinary Incontinence Drugs Price Analysis and Strategies - 2016" report to their offering....


Feb 24, 2017, 05:52 ET Xynomic Pharma Has Acquired Worldwide Rights of Abexinostat

Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights...


Feb 24, 2017, 04:28 ET Takeda y Cognition Kit se asocian en un estudio piloto de software que se puede llevar

- Takeda y Cognition Kit se asocian en un estudio piloto de software que se puede llevar en pacientes con enfermedad depresiva importante (MDD)...


Feb 24, 2017, 02:36 ET Medivir's Nomination Committee Proposes new Board of Directors Ahead of 2017 AGM

Medivir AB (Nasdaq Stockholm: MVIR) today announced the Nomination Committee's proposal for a new Board of Directors that will be submitted to the...


Feb 23, 2017, 23:41 ET Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017

Provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by the worlds leading...


Feb 23, 2017, 23:36 ET Global Melanoma Partnering 2010 to 2017

Provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds leading healthcare companies . Read...


Feb 23, 2017, 23:33 ET Global Ovarian Cancer Partnering 2010 to 2017

Provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies...


Feb 23, 2017, 22:58 ET Biomarkers Market by Product, Type, Disease Indication, Application - Global Forecast to 2021

Global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to...